DEBORAH HANKS: Open Payments
NPI 1780601542 · ORO VALLEY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,518 in 54 payments from 16 companies in 2025. Trend: 2023 $1,469 · 2024 $2,211 · 2025 $1,518
Food & beverage: $1,518
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $350 |
| GlaxoSmithKline, LLC. | 10 | $288 |
| AstraZeneca Pharmaceuticals LP | 9 | $277 |
| PFIZER INC. | 3 | $141 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $82 |
| Astellas Pharma US Inc | 3 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
| Exact Sciences Corporation | 3 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $41 |
| Merck Sharp & Dohme LLC | 2 | $40 |
Products named: AIRSUPRA, Ozempic, AREXVY, Wegovy, NURTEC ODT, TRELEGY ELLIPTA, Kerendia, Veozah.
Industry payments across AZ — which companies pay providers there.
